secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001493152-22-034836
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences prices $4.1M public offering of 2.9M shares and 5.8M warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.1M from offering of 2,900,000 shares (or pre-funded warrants) and 5,800,000 warrants at $1.40 combined price.
- Each warrant exercisable immediately at $1.40/share, expires 5 years from issuance.
- Underwriter (Lake Street Capital) granted 45-day option to purchase up to 342,000 additional shares and 870,000 warrants.
- 20% of gross proceeds to repay convertible notes; remainder for clinical development and working capital.
- Company directors and officers signed 90-day lock-up agreements restricting stock sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315222034836/0001493152-22-034836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315222034836/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-034836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer